AIDS 2024

About 1.2 million people around the world are infected with hepatitis B each year; the U.S. sees about 20,000 new ...

AUGUST 26, 2024

Current or previous use of the antiretroviral drug (ARV) abacavir was associated with an elevated risk for MACE in ...

AUGUST 14, 2024

Positive story about U.S.-Mexican border—Working together to reduce HIV and drug use among residents on both ...

AUGUST 2, 2024

A novel combination of bictegravir and lenacapavir appears highly effective in maintaining viral suppression over ...

JULY 26, 2024

Is it time to rethink the HIV testing algorithms among patients taking long-acting PrEP?

JULY 26, 2024

DoxyPrEP appears to be a promising strategy for preventing bacterial STIs among men who have sex with men, as well ...

JULY 25, 2024

Data from the IMPAACT 2017/MOCHA study support the use of long-acting Cabenuva among virologically suppressed ...

JULY 25, 2024

An interim analysis of PURPOSE 1 found twice-yearly lenacapavir was superior to once-daily oral FTC/TDF in ...

JULY 24, 2024

Dovato demonstrates high rates of virologic suppression among people living with HIV and who have reactive anti-HBc ...

JULY 23, 2024

Failling to meet global targets would result in tremendous human and economic consequences, according to a ...

JULY 22, 2024

The latest person to be cured of HIV has an important distinction from the previous six people—the stem cell ...

JULY 22, 2024